JOPIC
Journal of Pulmonology and Intensive Care

The JoPIC is an independent-unbiased, peer-reviewed, and open-access journal of current national and international issues and reviews for original clinical and experimental research, interesting case reports, surgical techniques, differential diagnoses, editorial opinions, letters to the editor, and educational papers in pulmonology, thoracic surgery, occupational diseases, allergology, and intensive care medicine.

eISSN: 2980-0803
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Case Report
A case of granulomatous lymphocytic interstitial lung disease considered as sarcoidosis
Abstract
Inborn errors of immunity (IEI), formerly referred to as primary immunodeficiency disorders, comprise ten groups and more than 500 distinct diseases. Common variable immunodeficiency (CVID) is the most prevalent symptomatic IEI in adults and is characterised by reduced immunoglobulin levels and recurrent infections after exclusion of secondary causes of hypogammaglobulinaemia. Granulomatous lymphocytic interstitial lung disease (GLILD) is a distinct clinical entity associated with CVID, defined by lymphoid proliferation and granuloma formation within the lung interstitium. GLILD shares numerous clinical, radiological, and pathological similarities with sarcoidosis; however, hypogammaglobulinaemia, indicative of immunodeficiency, is rarely encountered in sarcoidosis. To present a case initially diagnosed as sarcoidosis, in whom hypogammaglobulinaemia detected during follow-up led to the final diagnosis of primary immunodeficiency with granulomatous lymphocytic interstitial lung disease. This case report retrospectively reviews the patient’s clinical course, laboratory data, radiological findings, and histopathological results. Following the detection of hypogammaglobulinaemia, comprehensive immunological evaluation was performed, confirming the diagnosis of primary immunodeficiency. GLILD can closely mimic sarcoidosis in clinical, radiological, and pathological aspects. The presence of hypogammaglobulinaemia should prompt consideration of underlying primary immunodeficiency. This case highlights the importance of immunological assessment in patients with granulomatous interstitial lung disease to ensure accurate diagnosis and appropriate management.

Keywords : IEIs, GLILD, hypogammaglobulinemia, CVID, sarcoidosis

Download Article


1. Thalhammer J, Kindle G, Nieters A, et al. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations. J Allergy Clin Immunol. 2021;148(6):1332-1341.e5. doi:10.1016/j.jaci.2021.05.020
2. Seidel MG, Kindle G, Gathmann B, et al. The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity. J Allergy Clin Immunol Pract. 2019;7(6):1763-1770. doi:10.1016/j.jaip.2019.02.004
3. Chapel H, Lucas M, Lee M, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008;112(2): 277-286. doi:10.1182/blood-2007-11-124545
4. Park JH, Levinson AI. Granulomatous-lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID). Clin Immunol. 2010;134(2):97-103. doi:10.1016/j.clim.2009.09.006
5. Odnoletkova I, Kindle G, Quinti I, et al. The burden of common variable immunodeficiency disorders: a retrospective analysis of the European Society for Immunodeficiency (ESID) registry data. Orphanet J Rare Dis. 2018;13(1):201. doi:10.1186/s13023-018-0938-1
6. Fernández Pérez ER, Hunter M, Katial RK. United States trends in mortality rates for primary immunodeficiency diseases. J Allergy Clin Immunol Pract. 2019;7(3):1045-1048. doi:10.1016/j.jaip.2018.09.018
7. Abolhassani H, Azizi G, Sharifi L, et al. Global systematic review of primary immunodeficiency registries. Expert Rev Clin Immunol. 2020; 16(7):717-732. doi:10.1080/1744666X.2020.1788067
8. Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119(7):1650-1657. doi:10.1182/blood-2011-09- 379164
9. Cabañero-Navalon MD, Garcia-Bustos V, Nuñez-Beltran M, et al. Current clinical spectrum of common variable immunodeficiency in Spain: the multicentric nationwide GTEM-SEMI-CVID registry. Front Immunol. 2022;13:1033666. doi:10.3389/fimmu.2022.1033666
10. Tashtoush B, Memarpour R, Ramirez J, Bejarano P, Mehta J. Granulomatous-lymphocytic interstitial lung disease as the first manifestation of common variable immunodeficiency. Clin Respir J. 2018;12(1):337-343. doi:10.1111/crj.12525
11. Ho HE, Cunningham-Rundles C. Non-infectious complications of common variable immunodeficiency: updated clinical spectrum, sequelae, and insights to pathogenesis. Front Immunol. 2020;11:149. doi: 10.3389/fimmu.2020.00149
12. Leung J, Dorsey MJ, Dvorak CC, et al. Prevalence of granulomas in patients with primary immunodeficiency disorders, United States: data from national health care claims and the US Immunodeficiency Network Registry. J Clin Immunol. 2018;38(6):717-726. doi:10.1007/s 10875-018-0529-6
13. Mañá J, Gámez C, Salazar A, et al. Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis: cohort study of a 40-year clinical experience at a tertiary referral center in Barcelona, Spain. Medicine (Baltimore). 2017;96(29):e7595. doi:10. 1097/MD.0000000000007595
14. Mannina A, Chung JH, Swigris JJ, et al. Clinical predictors of a diagnosis of common variable immunodeficiency-related granulomatous-lymphocytic interstitial lung disease. Ann Am Thorac Soc. 2016;13(7):1042-1049. doi:10.1513/AnnalsATS.201601-061OC
15. Rubio-Rivas M, Franco J, Corbella X. Sarcoidosis presenting with and without Löfgren’s syndrome: clinical, radiological and behavioral differences observed in a group of 691 patients. Joint Bone Spine. 2020; 87(2):141-147. doi:10.1016/j.jbspin.2019.09.005
16. Cinetto F, Scarpa R, Pulvirenti F, et al. Granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID): a multicenter retrospective study of patients from Italian PID referral centers. Front Immunol. 2021;12:627423. doi:10.3389/fimmu. 2021.627423
17. Chawla S, Bhattarai P, Joshi AY, et al. Autoimmune cytopenias in common variable immunodeficiency are a diagnostic and therapeutic conundrum: an update. Front Immunol. 2022;13:869466. doi:10.3389/fimmu.2022.869466
18. Hurst JR, Verma N, Lowe D, et al. British Lung Foundation/United Kingdom Primary Immunodeficiency Network consensus statement on the definition, diagnosis, and management of granulomatous-lymphocytic interstitial lung disease in common variable immunodeficiency disorders. J Allergy Clin Immunol Pract. 2017;5(4): 938-945. doi:10.1016/j.jaip.2017.01.031
19. Verbsky JW, Routes JM, Kinney MC, et al. Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency. J Allergy Clin Immunol. 2021;147(2):704-712.e17. doi:10.1016/j.jaci.2020.07.031
20. Dhalla F, Lochlainn DJM, Chapel H, Patel SY. Histology of interstitial lung disease in common variable immune deficiency. Front Immunol. 2020;11:605187. doi:10.3389/fimmu.2020.605187
Article available in :
Volume 4, Issue 1, 2026
Page : 27-30
https://doi.org/10.51271/JOPIC-0075
Article Information
Received : 13 Ağu 2025
Accepted : 26 Ağu 2025
Published : 12 Şub 2026
Corresponding Author :

Güzin Özden: Division of Immunology and Allergy Diseases, Adana City Training and Research Hospital, University of Health Sciences, Adana, Turkiye

[email protected]
Citation : Çevirme L, Özden G, Şen N, Dik S, Erkoç M. A case of granulomatous lymphocytic interstitial lung disease considered as sarcoidosis. J Pulmonol Intens Care. 2026;4(1):27-30.

Read: 66
Download : 66
Cited: 0
_Footer